Roivant Sciences (ROIV) EBIT (2020 - 2026)
Roivant Sciences (ROIV) recorded EBIT of -$365.99 million in fiscal Q1 2027 (quarter ended Jun 30, 2026), compared with -$284.92 million a year earlier.
Powered by 
Analysis
Roivant Sciences (ROIV) EBIT (2020 - 2026) Analysis & Trends
On a TTM basis, Roivant Sciences' EBIT came in at -$596.14 million as of Jun 30, 2026; for FY2026 (ended Mar 31, 2026), it came in at -$515.07 million.
- Across earlier fiscal years, EBIT came in at -$1 billion in FY2025, $4.5 billion in FY2024, -$906.76 million in FY2023 and -$1.35 billion in FY2022.
- The fiscal Q1 2027 figure is the lowest quarterly EBIT since fiscal Q3 2023.
- Per Business Quant, the preceding three fiscal quarters came in at $415.24 million (Q4 2026), -$339.15 million (Q3 2026) and -$306.23 million (Q2 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,137.66 Bn | 1,106.24 Bn | 19.71 Bn | 11.75 Bn |
| 2 | Johnson & Johnson | 636.13 Bn | 556.00 Bn | 17.30 Bn | 6.18 Bn |
| 3 | AbbVie | 505.28 Bn | 478.39 Bn | 12.70 Bn | 6.43 Bn |
| 4 | Merck | 358.10 Bn | 312.48 Bn | 12.21 Bn | -584.00 Mn |
| 5 | Novartis Ag | 292.59 Bn | 256.58 Bn | 11.24 Bn | 4.75 Bn |
| 6 | Astrazeneca | 265.81 Bn | 239.50 Bn | 12.86 Bn | 3.16 Bn |
| 7 | Amgen | 237.53 Bn | 192.93 Bn | 7.24 Bn | 3.51 Bn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | -10.39 Bn |
| 9 | Pfizer | 171.17 Bn | 117.82 Bn | 10.94 Bn | 4.27 Bn |
| 10 | Roivant Sciences | 26.42 Bn | 9.37 Bn | 1.16 Mn | -365.99 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -365.99 Mn |
| Mar 31, 2026 | 415.24 Mn |
| Dec 31, 2025 | -339.15 Mn |
| Sep 30, 2025 | -306.23 Mn |
| Jun 30, 2025 | -284.92 Mn |
| Mar 31, 2025 | -284.97 Mn |
| Dec 31, 2024 | -274.38 Mn |
| Sep 30, 2024 | -341.71 Mn |
| Jun 30, 2024 | -102.24 Mn |
| Mar 31, 2024 | -206.83 Mn |
| Dec 31, 2023 | 5.13 Bn |
| Sep 30, 2023 | -213.89 Mn |
| Jun 30, 2023 | -276.41 Mn |
| Mar 31, 2023 | 34.39 Mn |
| Dec 31, 2022 | -378.08 Mn |
| Sep 30, 2022 | -280.77 Mn |
| Jun 30, 2022 | -282.31 Mn |
| Mar 31, 2022 | -266.80 Mn |
| Dec 31, 2021 | -246.02 Mn |
| Sep 30, 2021 | -684.43 Mn |
API Access
Roivant Sciences EBIT API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit&ticker=ROIV&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit", "ticker": "ROIV", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit&ticker=ROIV&period=max&api_key=YOUR_API_KEY");
const data = await res.json();